Frédéric Mascha Chief Executive Officer

As CEO, Frédéric is particularly engaged in overseeing the acquisition of pharmaceutical assets for Juvisé Pharmaceuticals and managing the associated financing.

Prior to Juvisé Pharmaceuticals, Frederic founded and led Lynapharm, a joint venture with the Italian pharmaceutical group Sigma-Tau, which was active in 22 countries with a focus on psychiatric medications. Sigma-Tau later acquired full ownership of Lynapharm.

Earlier in his career, Frederic served as an Associate Principal at McKinsey & Company, where he was instrumental in developing global pharmaceutical product launch strategies for leading companies such as Pfizer, BMS, JNJ, Sanofi…

Frédéric earned a management degree from Institut Supérieur de Gestion in Paris and an MBA from Harvard Business School.

Emilie Gounon Chief Operating Officer

Emilie Gounon holds a DESCF degree in Accounting and Finance from the University of Lyon 3. She began her career in Paris as an auditor before swiftly transitioning to the pharmaceutical industry, where she served as Financial Controller at Eisai for 10 years.

In 2013, Emilie joined Juvisé Pharmaceuticals as Chief Financial Officer & Operations Director. She advanced to the role of Chief Operating Officer in 2019, where she now oversees the company’s strategic and operational activities.

Antoine Guillot Vice President
Chief Financing Officer

As CFO, Antoine is responsible for overseeing accounting and financial activities, including tax management, financial control, debt management, and securing financing for new acquisitions. His expertise plays a crucial role in the growth and success of Juvisé Pharmaceuticals on the global stage.

Prior to joining Juvisé Pharmaceuticals, Antoine began his career as a financial auditor at KPMG for 5 years. He holds a Master’s degree in Accounting and Audit from the University of Grenoble and is a French certified public accountant.

Bruno Pouly Vice President
Pharmaceutical Affairs - Qualified Person

With over 20 years of experience in the pharmaceutical industry in manufacturing or Pharmaceutical Establishment, Bruno Pouly has been leading the Pharmaceutical Affairs department at Juvisé Pharmaceuticals since June 2020. He manages Regulatory Affairs, Pharmacovigilance, and Quality Assurance teams, maintaining marketing authorization dossiers, liaising with health authorities, and ensuring compliance with GMP, GDP, GVP and related regulations.

Previously, Bruno was Quality Director for the Centre Lago, where he registered the pharmaceutical establishment and was in charge of quality operations. He also held senior QA roles at Mylan and Capsugel.

Bruno holds a Pharmaceutical degree from the University of Claude Bernard in Lyon.

Antoine Rotger Vice President
Technical Operations

Antoine Rotger relies on over more than 15 years of experience in demanding industrial environments with a proven track record delivering impact and changes in organizations.

He began his career at McKinsey as a Lean Manufacturing specialist, then joined Michelin as manufacturing and planning manager. Before Juvisé Pharmaceuticals, he worked at Linxens, the global leading provider of micro-connectors, supporting one of the French sites in its industrial repositioning.

Since April 2021, Antoine has been Head of Industrial Operations at Juvisé. In this role, he oversees all purchasing, supply chain, manufacturing and industrial transfer operations, ensuring smooth and efficient delivery of products to patients.

Antoine holds an engineering degree from the École des Mines de Paris.

Allan Narboni Vice President
Commercial & Medical Operations

Allan Narboni is VP, Head of Operations at Juvisé Pharmaceuticals, overseeing the company’s functions in Marketing, Medical Affairs, Sales, Market Access, and Business Excellence.

With over 10 years in the pharmaceutical industry, Allan has held key positions at Les laboratoires SERVIER in EMEA & APAC at local and international level.

Allan holds a Pharm.D. from the Université libre de Bruxelles and completed his education with a Master degree from ESCP Business School.

Fiona Lecrinier Vice President
M&A and Corporate Development

Fiona Lecrinier is the Head of M&A and Corporate Development at Juvisé Pharmaceuticals and brings a strong background in strategic management and transaction with 10 years’ experience in the Pharmaceutical Industry. With nearly five years at Juvisé, she has also served as Transaction and Corporate Strategy Director and Business Development and Strategy Manager.

Before joining Juvisé, Fiona was a Senior Consultant at Simon-Kucher & Partners, where she specialized in healthcare strategy and innovative assets launch across various therapeutic areas and markets. She began her career at Servier, focusing on market analysis and business intelligence.

Fiona is a Doctor in Pharmacy and graduated from ESCP Business School.

Accueil Our company Our Executive Committee

Our Executive Committee

Juvisé Pharmaceuticals’ leadership

Based in France, the Executive Committee drives and implements Juvisé Pharmaceuticals’ strategy globally, ensuring effective execution across international markets.

Juvisé Pharmaceuticals’ leadership team is composed of the CEO and 6 executive members

Frédéric Mascha Chief Executive Officer

Emilie Gounon Chief Operating Officer

Antoine Guillot Vice President
Chief Financing Officer

Bruno Pouly Vice President
Pharmaceutical Affairs - Qualified Person

Antoine Rotger Vice President
Technical Operations

Allan Narboni Vice President
Commercial & Medical Operations

Fiona Lecrinier Vice President
M&A and Corporate Development

JUV-FRA-202408-0213, 09/2024

Vous souhaitez nous rejoindre ?

At Juvisé, every challenge is an opportunity to grow and innovate. We strive for excellence and go beyond expectations because we are committed to making a difference for the many patients who rely on us.